Scientists at the University of Edinburgh are developing multiplex microarray assays to accelerate routine blood typing and diagnosis of infectious diseases, using Tecan’s LS Reloaded™ laser scanner ...
Mass Spec Alternative Detects Biomarker Signatures in Tissues, Blood, and Cell Culture The current generation of antibody microarray technologies is providing highly sensitive new tools for screening ...
BERKELEY, CA — The dream of personalized medicine — in which diagnostics, risk predictions and treatment decisions are based on a patient's genetic profile — may be on the verge of being expanded ...
Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhibitors, ...
EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ -- AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® Celiac ...
Dublin, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The "Blood Group Typing Market by Product (Consumables, Instruments, Services), Test Type (ABO, Antigen, Antibody, HLA ...
The Genotyping Assay Market refers to the industry segment that develops and offers assays, kits, platforms, and services for determining genetic variations among individuals, including single ...
A new range of five instruments for ultra-low-volume liquid dispensing for microarray and microfluidics applications, Mercury, has been introduced by Arrayjet. Arrayjet, a provider of inkjet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback